| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| Cost of Revenue | $0 | -100.0% |
| R&D Expense | $27.8M | +33.4% |
| SG&A Expense | $15.8M | +13.1% |
| Operating Income | -$43.6M | +24.9% |
| Pre-tax Income | -$42.2M | +27.9% |
| Income Tax | $0 | — |
| Net Income | -$42.2M | +27.9% |
| EPS (Basic) | -$0.88 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.4M | -27.4% |
| Current Assets | $45.3M | -27.1% |
| Total Assets | $59.2M | -24.0% |
| Current Liabilities | $6.7M | +12.2% |
| Total Liabilities | $14.8M | -81.5% |
| Stockholders' Equity | $44.4M | +2073.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.0M | +29.7% |
| Capital Expenditures | $121K | -69.8% |
| Investing Cash Flow | -$121K | +69.8% |
| Financing Cash Flow | $16.4M | -79.5% |
| Free Cash Flow | -$33.2M | +30.1% |
| +48.8% |